Triple
T4501818
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Alexander Fleming |
E101237
|
entity |
| Predicate | nobelPrizeSharedWith |
P1859
|
FINISHED |
| Object | Howard Florey |
E339765
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Howard Florey | Statement: [Alexander Fleming, nobelPrizeSharedWith, Howard Florey]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Howard Florey Context triple: [Alexander Fleming, nobelPrizeSharedWith, Howard Florey]
-
A.
Howard Florey
chosen
Howard Florey was an Australian pharmacologist and pathologist who shared the Nobel Prize in Physiology or Medicine for his pivotal role in developing penicillin into a practical antibiotic treatment.
-
B.
Sir Frederick Gowland Hopkins
Sir Frederick Gowland Hopkins was an English biochemist and Nobel laureate renowned for discovering essential nutrients later known as vitamins and for pioneering the field of nutritional biochemistry.
-
C.
Harold Hodgkin
Harold Hodgkin is a notable individual who shares the Hodgkin surname, which is associated with several prominent figures in science and medicine.
-
D.
Sir James Black
Sir James Black was a Scottish pharmacologist and Nobel laureate renowned for developing the first beta-blocker and the H2 receptor antagonist cimetidine, revolutionizing treatments for heart disease and peptic ulcers.
-
E.
Julius Ehrlich
Julius Ehrlich is a notable individual associated with the surname Ehrlich, recognized as a distinguished bearer of that name.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd43d175248190894dc58b5b395c26 |
completed | March 20, 2026, 12:55 p.m. |
| NER | Named-entity recognition | batch_69bd56f9dca08190b926f40e201a3e97 |
completed | March 20, 2026, 2:17 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bd7f71de7081908520ebb81d184e0c |
completed | March 20, 2026, 5:10 p.m. |
Created at: March 20, 2026, 1 p.m.